Join
Live feed
·
INSIDERFilingvia Quantisnow
Interpace Biosciences, Inc. logo

Large owner 1315 Capital Ii, L.P. converted options into 9,405,941 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IDXG (Interpace Biosciences, Inc.) and more on Quantisnow.